Novanta (NOVT) Tops Q2 EPS by 7c ; Offers Guidance

Novanta (NASDAQ: NOVT) reported Q2 EPS of $0.80, $0.07 better than the analyst estimate of $0.73. Revenue for the quarter came in at $229.5 million versus the consensus estimate of $225.5 million.

GUIDANCE:

Novanta sees Q3 2023 EPS of $0.70-$0.77, versus the consensus of $0.82. Novanta sees Q3 2023 revenue of $221-224 million, versus the consensus of $229.6 million.

Novanta sees FY2023 EPS of $2.96-$3.15, versus the consensus of $3.14. Novanta sees FY2023 revenue of $892-902 million, versus the consensus of $907.8 million.

For earnings history and earnings-related data on Novanta (NOVT) click here.

You May Also Be Interested In

• Blackhawk Network (HAWK) Reports Q2 Loss of $0.07; Offers Guidance
• MapLight Therapeutics, Inc. (MPLT) Misses Q2 EPS by 33c
• Eledon Pharmaceuticals, Inc. (ELDN) Misses Q2 EPS by 12c